Get the Stockscreener App
86.47
1.89%
1.605
After Hours:
86.47
Soleno Therapeutics Inc stock is traded at $86.47, with a volume of 1.17M.
It is up +1.89% in the last 24 hours and up +3.21% over the past month.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.
See More
Previous Close:
$84.86
Open:
$85
24h Volume:
1.17M
Relative Volume:
1.12
Market Cap:
$4.36B
Revenue:
-
Net Income/Loss:
$-38.99M
P/E Ratio:
-28.86
EPS:
-2.9966
Net Cash Flow:
$-24.94M
1W Performance:
-1.77%
1M Performance:
+3.21%
6M Performance:
+72.15%
1Y Performance:
+79.29%
1-Day Range:
$84.74
$87.57
1-Week Range:
$83.53
$88.98
52-Week Range:
$41.50
$90.32
Soleno Therapeutics Inc Stock (SLNO) Company Profile
Name
Soleno Therapeutics Inc
Sector
Industry
Phone
650-213-8444
Address
100 MARINE PARKWAY, SUITE 400, REDWOOD CITY, CA
Compare SLNO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SLNO
Soleno Therapeutics Inc
|
86.47 | 4.48B | 0 | -38.99M | -24.94M | -2.9966 |
|
VRTX
Vertex Pharmaceuticals Inc
|
456.87 | 120.48B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
545.46 | 59.88B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
392.24 | 44.31B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
670.33 | 36.65B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
301.13 | 32.46B | 3.81B | -644.79M | -669.77M | -6.24 |
Soleno Therapeutics Inc Stock (SLNO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-23-25 | Initiated | TD Cowen | Buy |
| Mar-05-25 | Resumed | Stifel | Buy |
| Dec-02-24 | Reiterated | Robert W. Baird | Outperform |
| Dec-02-24 | Reiterated | Stifel | Buy |
| Sep-03-24 | Initiated | H.C. Wainwright | Buy |
| May-10-24 | Initiated | Robert W. Baird | Outperform |
| Feb-05-24 | Initiated | Piper Sandler | Overweight |
| Jan-23-24 | Initiated | Stifel | Buy |
| Nov-21-23 | Resumed | Guggenheim | Buy |
| Sep-29-20 | Initiated | Guggenheim | Buy |
| Jan-10-20 | Initiated | Craig Hallum | Buy |
| Dec-23-19 | Initiated | Oppenheimer | Outperform |
| Feb-13-18 | Reiterated | Maxim Group | Buy |
View All
Soleno Therapeutics Inc Stock (SLNO) Latest News
What makes Soleno Therapeutics Inc. stock price move sharplyStock Market Report For Consistent Profits - jammulinksnews.com
Live Scanner Shows Breakout on Soleno Therapeutics Inc.Growth Based Investment Plan Guidance Highlighted - metal.it
What does SLNO's flat EPS in 2024 indicate for future growth? - AInvest
Are analysts optimistic about SLNO's EPS turnaround? - AInvest
Can Soleno reverse its negative revenue trend? - AInvest
Soleno Therapeutics to Report Second Quarter 2025 Financial Results on August 6, 2025, at 4:30 PM ET - GlobeNewswire
When is Soleno Therapeutics Inc. stock expected to show significant growthSwing Trade Target Finder With Low Risk - jammulinksnews.com
Published on: 2025-07-28 20:12:42 - metal.it
What are the technical indicators suggesting about Soleno Therapeutics Inc.Achieve breakthrough financial results - jammulinksnews.com
What catalysts could drive Soleno Therapeutics Inc. stock higher in 2025Discover high-growth stocks for your portfolio - jammulinksnews.com
Rare Disease Biotech Soleno Sets Q2 Earnings Date: Key Updates on PWS Treatment Expected - Stock Titan
Is Soleno Therapeutics Inc. a growth stock or a value stockCapitalize on market trends with expert guidance - jammulinksnews.com
What is the risk reward ratio of investing in Soleno Therapeutics Inc. stockInvest in stocks with strong fundamentals - jammulinksnews.com
Soleno Therapeutics’ Vykat XR Exceeds Sales Expectations - MSN
What are analysts’ price targets for Soleno Therapeutics Inc. in the next 12 monthsStay ahead with advanced stock screening tools - jammulinksnews.com
Should I hold or sell Soleno Therapeutics Inc. stock in 2025Get professional advice for portfolio optimization - jammulinksnews.com
Published on: 2025-07-27 02:11:10 - metal.it
Is Soleno Therapeutics Inc. a good long term investmentFree Investment Community - PrintWeekIndia
Soleno Therapeutics stock dips on proposed $200M offering - MSN
Soleno Therapeutics, Inc. (SLNO) is a Great Momentum Stock: Should You Buy? - Yahoo Finance
Soleno Therapeutics Inc. Stock Analysis and ForecastFree Bull & Bear Market Updates - PrintWeekIndia
What analysts say about Soleno Therapeutics Inc. stock outlookSuperior profit margins - jammulinksnews.com
What drives Soleno Therapeutics Inc. stock priceFree Investment Portfolio Suggestions - PrintWeekIndia
Here's What Could Help Soleno Therapeutics (SLNO) Maintain Its Recent Price Strength - MSN
Can Soleno Therapeutics (SLNO) Climb 33.11% to Reach the Level Wall Street Analysts Expect? - MSN
What analysts say about Soleno Therapeutics Inc. stockFree Risk Assessment Services - Autocar Professional
Soleno’s Rare Disease Drug Launch Turns Heads On Wall Street - Finimize
Soleno Therapeutics Inc Stock (SLNO) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.43%
2.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):